Login / Signup

Albumin-myosteatosis gauge as a prognostic factor in patients with advanced pancreatic cancer undergoing first-line chemotherapy.

Taha Koray SahinYakup OzbayAhmet Yasir AltunbulakHalil Ibrahim AltunbulakMehmet Ruhi OnurFurkan CeylanDeniz Can GuvenSuayib YalcinOmer Dizdar
Published in: International journal of clinical oncology (2024)
The study findings suggest the prognostic value of AMG in patients with advanced PDAC undergoing first-line chemotherapy. Further studies are warranted to validate these findings and assess potential predictive role of AMG in guiding treatment selection.
Keyphrases
  • prognostic factors
  • locally advanced